Division of Obstetrics and Fetal Medicine.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Erasmus University Medical Center, Rotterdam, Netherlands.
Curr Opin Obstet Gynecol. 2020 Jun;32(3):169-178. doi: 10.1097/GCO.0000000000000626.
Herein, we present an overview of the recent microbiome research and findings within the field of reproductive medicine and its relation with the outcome of Assisted reproductive technology (ART). Analyses of the microbiome composition all throughout the female reproductive trace during the process of assisted reproductive techniques are discussed.
Only the vaginal microbiome can be sampled without possible risks of contamination. Although this also seems to apply to the cervical microbiome, collection has to be performed with extreme caution. Because of the high risk of cross contamination, results of microbial composition of all other sites of the female reproductive tract have to be interpreted with caution. The vaginal composition prior to the start of hormonal treatment for ART seems to be predictive of in vitro fertilization/in vitro fertilization-intracytoplasmic sperm injection (IVF/IVF-ICSI) outcome, with mainly a highly negative predictive value.
The local microbiota, especially the absence or presence of specific microbes, within parts of the female reproductive tract seem to be associated with the outcome of ART.
本文综述了生殖医学领域中微生物组学的最新研究和发现及其与辅助生殖技术(ART)结局的关系。讨论了在辅助生殖技术过程中女性生殖道各个部位的微生物组组成的分析。
只有阴道微生物组可以无潜在污染风险进行采样。虽然这似乎也适用于宫颈微生物组,但采集必须极其谨慎。由于高度交叉污染的风险,女性生殖道其他部位的微生物组成结果必须谨慎解释。ART 前激素治疗开始前的阴道组成似乎可以预测体外受精/卵胞浆内单精子注射(IVF/IVF-ICSI)的结局,主要是具有高度阴性预测值。
女性生殖道内局部微生物群,尤其是特定微生物的缺失或存在,似乎与 ART 的结局相关。